Systemic lupus erythematosus (SLE)

(ERA-EDTA) If renal remission is achieved therapeutically in cases of lupus nephritis (LN), the 10-year survival rate increases significantly. Successful therapy is therefore of great importance. As a recent presentation at the ERA-EDTA Congress showed, this can be achieved by additional administration of belimumab.